Business investment AMSbiopharma. Expansion of the capacity of an existing facility (IG253.2019.1.62).

Objective: We seek to increase our portfolio of services for the pharmaceutical sector and for this it is essential to acquire the latest technology equipment to meet the needs of this sector. Due to the requirements in the pharmacopoeia sector, all the equipment must be of exclusive use, which forces us to equip ourselves with new equipment, high technology equipment that will allow us to meet the needs of our customers.

This company was the beneficiary of a grant from IGAPE’s business investment program, which aims to foster the balanced development of the Galician territory and promote the growth and consolidation of SMEs.

Operation co-financed by the European Union.

Galicia ERDF Operational Program 2014-2020.

Achieving a more competitive business fabric.
A way of making Europe.

AMSbiopharma’s digitalization process (IG240.2019.1.54)

Objective: Implementation of Part 11 CRF 21 certification.

Results: It allows us the secularized traceability of the processes of primary data generation, acquisition, processing, reporting, encryption and archiving of digital data obtained with the Sciex 5500 equipment in its application in studies in GLP environment.

This company was the beneficiary of a grant from IGAPE’s “Industry 4.0 digitalization” program, which aims to promote the digital transformation of the company and favor the growth and consolidation of SMEs, improving their financing, technology and access to advanced support services.

Operation co-financed by the European Union.

Galicia ERDF Operational Program 2014-2020.

Achieving a more competitive business fabric.
A way of making Europe.

Staff co-funded by the Xunta de Galicia outside the Resolution of the Axencia Galega de Innovación of May 29, 2019.
04_IN858A_2019_1642437